✦ LIBER ✦
Heart rate-lowering calcium channel blockers (diltiazern, verapamil) do not adversely affect long-term cardiac death or non-fatal infarction in post-infarction patients: Data pooled from 3 randomized, placebo-controlled clinical trials of 5,677 patients
✍ Scribed by Boden, William E.; Messerli, Franz H.; Hansen, Jørgen Fischer; Schechtman, Kenneth B.
- Book ID
- 122613918
- Publisher
- Elsevier Science
- Year
- 1996
- Tongue
- English
- Weight
- 139 KB
- Volume
- 27
- Category
- Article
- ISSN
- 1558-3597
No coin nor oath required. For personal study only.